J Headache Pain 63(5):601610 Zelissen PM et al (1991) Calcitonin gene-related peptide in human obesity
BPC 157, the talk of the town, is making waves for its potential healing benefits
The recommended semaglutide dosing schedule, as per the prescribing information and clinical trials, is as follows: Administer WEGOVY once weekly, on the same day each week, at any time of day, with or without meals Inject subcutaneously in the abdomen, thigh or upper arm (alternate injection site) In 4 week intervals, increase the dose until a dose of 2.4 mg is reached
studies provide compelling evidence that semaglutide use in orthopedic surgery is associated with lower rates of infection, readmission, and revision surgery, likely due to improved metabolic control, reductions in systemic inflammation, and weight loss-driven perioperative risk reduction
No, they won't do it